A Novel Scale System Based on the Frailty Index and Laboratory Indicators for the Short-Term Prognosis of Patients with Acute Myocardial Infarction: A Retrospective Cohort Study
Tianqing Cao,Fei Liu,Yan Yao,Danghong Sun,Rong Wang,Junxia Cao,Jie Meng,Ling Zhang,Weiming Li
DOI: https://doi.org/10.2147/cia.s469480
IF: 3.829
2024-09-27
Clinical Interventions in Aging
Abstract:Tianqing Cao, 1, &ast Fei Liu, 2, &ast Yan Yao, 2 Danghong Sun, 2 Rong Wang, 3 Junxia Cao, 3 Jie Meng, 2 Ling Zhang, 4 Weiming Li 1 1 Shanghai Tenth People's Hospital, Clinical Medical College of Nanjing Medical University, Nanjing, People's Republic of China; 2 Department of Cardiology, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, People's Republic of China; 3 Department of Pulmonology, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, People's Republic of China; 4 Department of Nursing, Changshu No.2 People's Hospital/Affiliated Changshu Hospital of Nantong University, Changshu, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Weiming Li; Ling Zhang, Email ; Objective: Current scoring systems for short-term prognosis in patients with acute myocardial infarction (AMI) lack coverage of risk factors and have limitations in risk stratification. The aim of this study was to develop a novel assessment system based on laboratory indicators and frailty quantification to better infer short-term prognosis and risk indication in patients with AMI. Methods: A total of 365 patients with MI from January 2022 to June 2023 in Northern Jiangsu Province Hospital were included. The primary endpoint was all-cause mortality and major adverse cardiac events (MACE) during follow-up. A novel scoring model ranging from 0 to 12 was constructed, and the predictive ability of this scoring system was evaluated using the area under the receiver operating characteristic curve (AUC). Results: During follow-up, 68 patients experienced MACE. Five scoring indicators were selected through multivariate logistic regression analysis, resulting in a composite score with an AUC of 0.925, demonstrating good prognostic accuracy. Conclusion: The novel prognostic assessment system, which integrates age, Stress Hyperglycemia Ratio (SHR), Neutrophil to Lymphocyte Ratio (NLR), lactate, and frailty score, exhibits good predictive value for short-term MACE in patients with acute myocardial infarction and may enable more accurate risk classification for future use in MI patient risk management. Keywords: myocardial infarction, frailty index, major adverse cardiac events, prognosis, cohort study With the advancement of early revascularization and medical preventive strategies, especially the widespread use of percutaneous coronary intervention (PCI), the prognosis of patients with acute myocardial infarction (AMI) has been greatly improved. However, AMI remains one of the leading causes of morbidity and mortality globally, with adverse cardiac events such as heart failure persisting in the short-term prognosis of MI. Frailty is commonly regarded as a state characterized by reduced physiological reserves and loss of resistance to stressors, manifested as poor physical activity, decreased muscle mass, poor nutritional status, and cognitive decline. Numerous studies have shown that frailty is a favorable predictor of adverse outcomes and mortality in patients with acute myocardial infarction. 1 The Fried frailty phenotype and Clinical Frailty Scale (CSF) are commonly used assessment tools for frailty, validated extensively in research and clinical practice. 2 Various scoring systems, such as the GRACE risk score, have been used to assess cardiovascular risk. Objective risk assessment helps to avoid the influence of subjective judgments by physicians on risk discrimination and plays an important role in personalized patient risk assessment and survival prediction. 3 As a guideline-recommended MI management risk model, the GRACE risk score is mainly used to predict mortality after 6 months but has limited predictive efficacy for short-term prognosis, and most current risk assessment models tend to be disease-related dimensions. 4 Indeed, biomarkers and laboratory indicators play an indispensable role in assisting timely diagnosis and accurate prediction of short-term prognosis. The levels of different biomarkers can reflect different pathological and physiological processes. 5 Various types of laboratory indicators have been used for cardiovascular disease risk prediction. For example, platelet count is an important parameter for the diagnosis, treatment, and prognosis assessment of circulatory failure-related diseases, 6 Short-term follow-up B-type natriuretic peptide (BNP) levels have been shown to be reliable predictors of short-term prognosis in acute coronary syndrome. 7 In addition, common prognostic risk factors include creatinine clearance, homocysteine, etc.<sup -Abstract Truncated-
geriatrics & gerontology,gerontology